Skip to main navigation

Science
Pipeline
About Us
Investors
Contact
Careers

Quarterly Results

Designed to Optimize Impact

Overview
News
Events & Presentations
toggle Stock Information sub-menu
- Stock Quote & Chart
- Analyst Coverage
toggle Corporate Governance sub-menu
toggle Financials & Filings sub-menu
toggle IR Resources sub-menu

Shareholder Tools

Print Page
Email Alerts
RSS Feeds
Site Map

Show all

2026

First Quarter

ALX Oncology Reports First Quarter 2026 Financial Results and Provides Corporate Update
Form 10-Q

2025

Fourth Quarter

ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Form 10-K

Third Quarter

ALX Oncology Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Form 10-Q

Second Quarter

ALX Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Form 10-Q

First Quarter

ALX Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update
Form 10-Q

2024

Fourth Quarter

ALX Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Form 10-K

Third Quarter

ALX Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Form 10-Q

Second Quarter

ALX Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Form 10-Q

First Quarter

ALX Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update
Form 10-Q

2023

Fourth Quarter

ALX Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Form 10-K

Third Quarter

ALX Oncology Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Form 10-Q

Second Quarter

ALX Oncology Reports Second Quarter 2023 Financial Results and Provides Clinical Program Update
Form 10-Q

First Quarter

ALX Oncology Reports First Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights
Form 10-Q

2022

Fourth Quarter

ALX Oncology Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Development and Operational Highlights and Upcoming Milestones
Form 10-K

Third Quarter

ALX Oncology Reports Third Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights
Form 10-Q

Second Quarter

ALX Oncology Reports Second Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights
Form 10-Q

First Quarter

ALX Oncology Reports First Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights
Form 10-Q

2021

Fourth Quarter

ALX Oncology Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Clinical Development and Operational Highlights and Upcoming Milestones
Form 10-K

Third Quarter

ALX Oncology Reports Third Quarter 2021 Financial Results and Provides Clinical Development and Operational Highlights
Form 10-Q

Second Quarter

ALX Oncology Reports Second Quarter 2021 Financial Results and Provides Clinical Development and Operational Highlights
Form 10-Q

First Quarter

ALX Oncology Reports First Quarter 2021 Financial Results and Provides Clinical Development and Operational Highlights
Form 10-Q

2020

Fourth Quarter

ALX Oncology Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Clinical Development and Operational Highlights and Upcoming Milestones
Form 10-K

Third Quarter

ALX Oncology Reports Third Quarter 2020 Financial Results and Provides Clinical Development and Operational Highlights
Form 10-Q

Second Quarter

ALX Oncology Reports Second Quarter 2020 Financial Results and Provides Operational and Clinical Highlights
Form 10-Q

Shareholder Tools

Print Page
Email Alerts
RSS Feeds
Site Map

Designed to Optimize Impact

Contact

(650) 466-7125

323 Allerton Avenue

South San Francisco, CA 94080

Contact Us

Science
Pipeline
About Us
Investors
Contact
Careers

Terms of Use
Privacy Policy